fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Child undernutrition may be contributing to global measles outbreaks, researchers find

Written by | 19 Jan 2025

Amid a global surge in measles cases, new research suggests that undernutrition may be exacerbating outbreaks in areas suffering from food insecurity. A study involving over 600 fully… read more.

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Written by | 31 Dec 2024

A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new… read more.

Phase IV data demonstrates Dovato (DTG/3TC) is highly effective in treatment naive people with advanced HIV – Viiv Healthcare

Written by | 15 Nov 2024

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders announced 48-week findings from the DOLCE study, sponsored by Fundación Huésped… read more.

Mosquitoes importing malaria to Europe via air travel

Written by | 4 Nov 2024

Malaria cases resulting from bites of mosquitoes transported by aircraft from areas where the disease is common have increased, according to two new studies: a retrospective analysis in… read more.

RSV vaccines effective, but more people need to get them

Written by | 31 Oct 2024

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines. In a recent commentary in The Lancet, Angela Branche, MD,… read more.

Sanofi Showcases Groundbreaking Beyfortus Data at IDWeek 2024, Highlighting Over 80% Effectiveness in Protecting Infants Against RSV

Written by | 18 Oct 2024

Sanofi advances its ambition to protect all infants from respiratory syncytial virus (RSV) disease with new Beyfortus (nirsevimab) data to be presented at the Infectious Disease Society of… read more.

A two-dose schedule could make HIV vaccines more effective

Written by | 24 Sep 2024

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response… read more.

First real-world analysis of Ebola vaccine reveals 84% effectiveness during Democratic Republic Congo outbreak – Merck Inc

Written by | 28 Aug 2024

When a deadly outbreak of the Ebola virus spread through the Democratic Republic of Congo in 2018, Merck’s then-unapproved vaccine (Ervebo) was quickly deployed to help address the… read more.

Vir Biotechnology to withdraw from infectious diseases research

Written by | 6 Aug 2024

Vir Biotechnology is cutting one-quarter of its workforce in a move away from infectious disease research. The company, which rose to prominence with its coronavirus antibody work in… read more.

Only around half of individuals disclose or believe they should reveal having an STI prior to sexual intercourse, research to-date suggests

Written by | 10 Jun 2024

A review of research to-date reveals the complex nature of revealing a diagnosis of a sexually transmitted infection (STI) to a partner ahead of engaging in sexual activity…. read more.

Antimicrobial-resistant hospital infections remain at least 12% above pre-pandemic levels, major US study finds

Written by | 2 May 2024

Despite progress in combating antimicrobial resistance (AMR) in the USA since its peak during the COVID-19 pandemic, hospital-acquired AMR infections remain well above pre-pandemic levels, according to a… read more.

Transmission risk of multidrug-resistant bacteria appears highest in hospital sinks

Written by | 27 Apr 2024

A new study published today in the American Journal of Infection Control (AJIC) reports the infection prevention steps taken to control a months-long multispecies outbreak of carbapenemase-producing Enterobacterales that occurred in a… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.